Taiwan FDA registration 4b4eeb47c5afbdc870946e2715d66008

BD Gram-Positive Identification and Drug Susceptibility Reagent Panel

TW: BD 革蘭氏陽性菌鑑定及藥物敏感性試劑組

Taiwan·Risk Class 2·BECTON DICKINSON AND COMPANY·Registered Oct 25, 2023 – Oct 25, 2028Active

Registration details

Analysis ID: 4b4eeb47c5afbdc870946e2715d66008
Customs Code: DHA05603623107

Company information

Manufacturer: BECTON DICKINSON AND COMPANY
Manufacturer Country: United States
Authorized Representative: BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE)

Product details

Intended Use: This product is used for the identification and drug tolerance test of most gram-positive aerobic bacteria and facultative anaerobes of human origin, and must be used with Phoenix automatic microbial system instruments.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Oct 25, 2023
Expiry Date: Oct 25, 2028

About this record

Access comprehensive regulatory information for BD Gram-Positive Identification and Drug Susceptibility Reagent Panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4b4eeb47c5afbdc870946e2715d66008 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.